You are here

Home 🌿 Medical Cannabis News 🌿 Cannabis vs. COVID: What the research is showing 🌿

Cannabis vs. COVID: What the research is showing

Warning message

The subscription service is currently unavailable. Please try again later.
Twitter icon
Submitted by Cannabis News on Wed, 01/19/2022 - 11:52
girl in mask

A study last week from two Oregon universities has generated a lot of buzz, after findings suggested that some cannabis compounds may be able to block the SARS-CoV-2 virus from entering human cells. It adds to a growing body of research on cannabis and the coronavirus, as studies from around the world — including from Canada — have found that the cannabis compound CBD may be effective in helping treat some of the virus’s most deadly symptoms.  

e-mail icon Facebook icon Twitter icon LinkedIn icon Reddit icon
Rate this article: 
Authored By: 
CBC
Article category: 
Medical Cannabis News
Regional Marijuana News: 
North America

420 Intel is Your Source for Marijuana News

420 Intel Canada is your leading news source for the Canadian cannabis industry. Get the latest updates on Canadian cannabis stocks and developments on how Canada continues to be a major player in the worldwide recreational and medical cannabis industry.

420 Intel Canada is the Canadian Industry news outlet that will keep you updated on how these Canadian developments in recreational and medical marijuana will impact the country and the world. Our commitment is to bring you the most important cannabis news stories from across Canada every day of the week.

Marijuana industry news is a constant endeavor with new developments each day. For marijuana news across the True North, 420 Intel Canada promises to bring you quality, Canadian, cannabis industry news.

You can get 420 Intel news delivered directly to your inbox by signing up for our daily marijuana news, ensuring you’re always kept up to date on the ever-changing cannabis industry. To stay even better informed about marijuana legalization news follow us on Twitter, Facebook and LinkedIn.